Establishment Labs Holdings (ESTA) Total Non-Current Liabilities (2017 - 2026)
Establishment Labs Holdings (ESTA) recorded quarterly Total Non-Current Liabilities of $334.2 million in Q1 2026, up 0.5% quarter-over-quarter from $332.5 million in Q4 2025, and up 13.97% on a YoY basis from $293.2 million in Q1 2025.
Establishment Labs Holdings (ESTA) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $334.2 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 13.97% year-over-year to $334.2 million; the TTM figure through Mar 2026 stood at $334.2 million (up 13.97% YoY), while the FY2025 annual figure was $332.5 million, up 13.84% from the prior year.
- Total Non-Current Liabilities was $334.2 million for Q1 2026 at Establishment Labs Holdings, up from $332.5 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $334.2 million in Q1 2026 to a low of $92.6 million in Q1 2022.
- Historically, Total Non-Current Liabilities has averaged $248.5 million across 5 years, with a median of $243.4 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities soared 151.88% in 2022, then advanced 4.25% in 2024.
- A 5-year view of Total Non-Current Liabilities shows it stood at $217.6 million in 2022, then advanced by 14.24% to $248.6 million in 2023, then gained by 17.48% to $292.1 million in 2024, then gained by 13.84% to $332.5 million in 2025, then rose by 0.5% to $334.2 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $334.2 million (Q1 2026), $332.5 million (Q4 2025), and $321.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Establishment Labs Holdings | 2.54 Bn | 2.47 Bn | 42.34 Mn | 334.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 334.15 Mn |
| Dec 31, 2025 | 332.48 Mn |
| Sep 30, 2025 | 321.42 Mn |
| Jun 30, 2025 | 305.24 Mn |
| Mar 31, 2025 | 293.18 Mn |
| Dec 31, 2024 | 292.06 Mn |
| Sep 30, 2024 | 248.68 Mn |
| Jun 30, 2024 | 238.61 Mn |
| Mar 31, 2024 | 243.38 Mn |
| Dec 31, 2023 | 248.60 Mn |
| Sep 30, 2023 | 238.54 Mn |
| Jun 30, 2023 | 228.43 Mn |
| Mar 31, 2023 | 223.53 Mn |
| Dec 31, 2022 | 217.62 Mn |
| Sep 30, 2022 | 183.89 Mn |
| Jun 30, 2022 | 181.96 Mn |
| Mar 31, 2022 | 92.62 Mn |
| Dec 31, 2021 | 86.40 Mn |
| Sep 30, 2021 | 84.65 Mn |
| Jun 30, 2021 | 81.07 Mn |